Type and composition of surfactants mediating gene transfection of polyethylenimine-coated liposomes by Opanasopit, Praneet et al.
© 2011 Opanasopit et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of Nanomedicine 2011:6 975–983
International Journal of Nanomedicine Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
975
OrIgINAL reseArch
open access to scientific and medical research
Open Access Full Text Article
DOI: 10.2147/IJN.s18647
Type and composition of surfactants mediating 
gene transfection of polyethylenimine-coated 
liposomes
Praneet Opanasopit1
Orapan Paecharoenchai1
Theerasak rojanarata1
Tanasait Ngawhirunpat1
Uracha ruktanonchai2
1Faculty of Pharmacy, silpakorn 
University, Nakhon Pathom, 2National 
Nanotechnology center, Thailand 
science Park, Pathumthani, Thailand
correspondence: Praneet Opanasopit 
Faculty of Pharmacy, silpakorn University, 
Nakhonpathom, 73000, Thailand 
Tel +66 3425 5800 
Fax +66 3425 5801 
email praneet@su.ac.th
Background: The objective of this study was to compare the transfection efficiency of anionic 
liposomes coated with polyethylenimine (PEI) with that of PEI and Lipofectamine 2000TM using 
the plasmid DNA encoding green fluorescent protein in a human hepatoma (Huh7) cell line.
Methods: Factors affecting transfection efficiency, including type of surfactant, ratio of phos-
phatidylcholine (PC)/surfactant, carrier/DNA weight ratio, and the presence of serum have 
been investigated. Anionic liposomes, composed of PC and anionic surfactants, ie, sodium 
oleate (NaO), sodium taurocholate (NaT), or zwitterionic surfactant (3-[{3-cholamidopropyl}-
dimethylammonio]-1-propanesulfonate, CHAPS) at molar ratios of 10:1, 10:1.5, and 10:2 
were prepared by the sonication method. Subsequently, they were coated with PEI to produce 
polycationic liposomes (PCL).
Results: PCL was able to condense with pDNA depending on the PCL/DNA weight ratio. 
PCL composed of PC:NaO (10:2) showed higher transfection efficiency than NaT and CHAPS 
at all weight ratios tested. Higher transfection efficiency and gene expression were observed 
when the carrier/DNA weight ratio increased. The highest transfection efficiency was found 
at a weight ratio of 0.5.
Conclusion: This PCL showed remarkably high transfection efficiency with low cytotoxicity 
to Huh7 cells in vitro, in comparison with PEI and Lipofectamine 2000.
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Introduction
Gene delivery has been regarded as a powerful tool for curing disease by replacing 
defective genes, substituting missing genes, or silencing unwanted gene expression. 
The two main types of vectors used in gene therapy are viral and nonviral vectors. 
Among the nonviral vectors, cationic liposomes1–3 and polycations4,5 have been widely 
investigated. Cationic liposomes form a complex with anionic DNA molecules and are 
thought to deliver DNA through the endosomal pathway.6 The precise mechanism for 
gene transfection mediated by cationic liposomes is still unclear. However, fusion with 
the endosomal membrane or destabilization of the membrane by cationic liposomes 
may trigger the effective cytosolic delivery of DNA.7,8 However, the cationic liposomal 
system has some disadvantages, such as low efficiency of transfection, due to DNA 
degradation in lysosomes, and strong cytotoxicity.9 On the other hand, polycations, 
such as polyethylenimine (PEI), also form a complex with anionic DNA molecules 
and are taken up into target cells via the endosomal pathway. However, in the case 
of polycations, unlike cationic liposomes, the DNA released into the cytoplasm from International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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endosomes, due to the proton-sponge effect of PEI, may 
further be delivered to the nucleus by the polycation.10,11
Yamazaki et al12,13 prepared polycation liposomes (PCL) 
by modification of a liposome with cetyl PEI, and found that 
PCL could actually deliver genes effectively in the presence 
of serum and in vivo with low cytotoxicity. The mechanism 
for effective gene transfer by PCL was that PCL transfer DNA 
to endosomes and release cetyl PEI/DNA complexes into 
the cytosol. Furthermore, cetyl PEI also contributes to gene 
entry into the nucleus.14 Chen et al15 also prepared PCL using 
PEI (molecular weight 800) and cholesterol. These PCL had 
transfection efficiency equivalent to that of Lipofectamine 
2000™ with significantly low cytotoxicity. In general, the 
key step of gene delivery is thought to be not the delivery 
of DNA into the cytosol through the endosomal pathway 
but rather the entry of cytosolic DNA into the nucleus when 
cationic liposomes are used as a nonviral vector.16 Therefore, 
gene delivery is cell-cycle dependent, and effective gene 
delivery is achieved only in dividing cells. If PEI has the 
ability to enter into the nucleus in nondividing cells, then PCL 
may have the dual advantage of both cationic liposomes for 
cytosolic delivery of DNA and polycations for delivery of 
cytosolic DNA into the nucleus. Alternatively, if PEI cannot 
pass through the nuclear membrane, it still has the ability to 
enhance interaction of foreign DNA with   chromatins during 
cell division.
Although many researchers have attempted to develop 
an effective nonviral gene transfer system by combination 
of both cationic liposomes and polycations as an alternative 
gene carrier, few have been successful in increasing transfec-
tion efficiency. Lampela et al have reported that the use of 
PEI cationic liposomes (Dosper) for nonviral gene delivery 
showed synergism between cationic lipid Dosper and small 
molecular weight PEI in transfection.17 They suggested that 
this synergism was based on two independent mechanisms, 
ie, the liposome improves cellular uptake of PEI/DNA 
  complexes, and PEI improves the transfer of the complexes 
from the lysosomes to the nucleus. They found that high 
molecular weight PEI with linear (PEI 22 K) and branched 
(PEI 25 K) structures in combination with Dosper liposomes 
could be used to increase the efficiency of gene delivery in 
vitro.18 Moreover, they combined low molecular weight PEI 
(MW 700 and 2000) with Superfect (a dendrimer) and two 
liposomes, ie, Dotap (N-[1-{2,3-dioleoyloxy}propyl]-N,N,N-
trimethylammonium methylsulfate) and Lipofectamine. 
The highest synergism was achieved with Lipofectamine 
and PEI in Rabbit smooth muscle (SMC)  cells, or with 
Dotap and PEIs in rat glioma (C6) cells. Superfect did not 
induce any synergism.19 Therefore, in this study,   PEI-coated 
liposomes with   different compositions were   prepared to 
investigate the physicochemical properties intended for 
gene delivery.   Surfactants, ie, (3-[{3-Cholamidopropyl} 
dimethylammonio]-1-  propanesulfonate, CHAPS), sodium 
taurocholate (NaT), or sodium oleate (NaO) was added to 
phosphatidylcholine (PC) to form an anionic liposome. A 
number of variables influencing   transfection efficiency, such 
as carrier/DNA weight ratio, type of surfactants (CHAPS, 
NaT and NaO), particle size, zeta potential, morphology, 
and serum were   investigated. In vitro gene transfection 
assay was performed with a human   hepatoma (Huh7) cell 
line using plasmid DNA encoding green fluorescent protein 
(pEGFP-C2).   Evaluation of cytotoxicity was performed 
by the MTT assay. The results revealed that PEI-coated 
anionic liposomes PC:NaO (10:2) showed high transfection 
efficiency with low cytotoxicity to Huh7 cells in vitro, in 
comparison with PEI and   Lipofectamine 2000.
Material and methods
Materials
Egg yolk PC was purchased from Wako Pure   Chemical 
(Osaka, Japan). Branched PEI, (molecular weight 25 kDa, 
3-[{3-Cholamidopropyl}dimethyl ammonio]-1-propane-
sulfonate, CHAPS), sodium oleate (NaO), and sodium 
  taurocholate (NaT), Tris, Triton-X 100, and   3-(4,5-dimethylth
iazol-2-yl)-2,5-diphenyl tetrazolium   bromide (MTT) were pur-
chased from Sigma Chemical Co (St Louis, MO).   Dulbecco’s 
modified Eagle’s medium (DMEM), trypsin-ethylenediamine 
tetra-acetic acid (EDTA), penicillin-  streptomycin antibiotics, 
fetal bovine serum, and Lipofectamine 2000 were obtained from 
Gibco Invitrogen (Grand Island, NY). pEGFP-C2 was obtained 
from Clontech (Palo Alto, CA). The λDNA/HindIII marker was 
obtained from Promega (Madison, WI). Human hepatocellular 
carcinoma (Huh7) cells were obtained from the American Type 
Culture Collection (Rockville, MD). All other chemicals were 
of cell culture and molecular biology quality.
Plasmid preparation
pEGFP-C2 was propagated in Escherichia coli DH5-α 
and purified using the Qiagen endotoxin-free plasmid puri-
fication kit (Qiagen, Santa Clarita, CA). DNA concentration 
was quantified by the measurement of ultraviolet absor-
bance at 260 nm using a GeneRay ultraviolet photometer 
(Biometra® , Goettingen, Germany). The purity of the plasmid 
was verified by gel electrophoresis (0.8% agarose gel) in Tris 
acetate-EDTA buffer, pH 8.0, and using λDNA/HindIII as 
a DNA marker.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Preparation of PeI-coated liposomes
Different formulations composed of a bilayer forming PC, 
in combination of NaO, CHAPS, or NaT, in molar ratios 
of 10:1, 10:1.5, and 10:2, were prepared by the sonication 
method. Briefly, PC, CHAPS, NaO, and NaT were separately 
dissolved in chloroform:methanol (2:1 v/v). The materials 
were deposited in a test tube and the solvents were evaporated 
under nitrogen gas flow. The lipid film was placed in a desic-
cator connected to a vacuum pump for six hours to remove 
remaining organic solvents. The dried lipid film was hydrated 
with Tris buffer (20 mM Tris and 150 mM NaCl, pH 7.4). 
Following hydration, the dispersion was sonicated in a bath 
sonicator for 10 minutes and then in a probe sonicator, each 
for 30 minutes in two cycles. For PEI-coated liposomes, the 
liposomes were mixed with PEI solution (1 mg/mL) at the 
ratio of 1:1 (w/w) with a magnetic stirrer for 30 minutes.
Preparation and characterization  
of PcL/DNA complexes
The PCL/DNA complexes were prepared at various carrier/
DNA weight ratios by adding DNA solution to the PCL 
solution. The mixture was gently mixed using a pipette for 
3–5 seconds to initiate complex formation and was left for 
15 minutes at room temperature. The complex formation 
was confirmed by electrophoresis. Agarose gels were pre-
pared with 1% agarose solution in Tris acetate-EDTA buf-
fer with ethidium bromide 0.5 µg/mL. The electrophoresis 
was   carried out for 60 minutes at 100 V . The volume of the 
sample loaded in the well was 15 µL of PCL/DNA complex 
containing 1 µg of DNA.
size and zeta potential measurements
The particle size and surface charge of the PCL/DNA com-
plexes were determined by photon correlation spectroscopy 
using the Zetasizer Nano ZS (Malvern Instruments Ltd, 
Malvern, UK) at room temperature. The complexes were 
diluted with distilled water which was previously passed 
through a 0.22 µm membrane filter. All samples were 
  measured in triplicate.
Morphology
The morphology of the PCL/DNA complexes was analyzed 
by transmission electron microscopy and atomic force 
microscopy. Analyzed by transmission electron microscopy, 
3% solution of Formvar was prepared in spectroscopic-grade 
chloroform. Then, one drop of the sample solution of PCL/
DNA complex was put on a Formvar-coated carbon ultrathin 
grid and air-dried. The dried grid was then examined by 
transmission electron microscopy (JEOL JEM1230, Tokyo, 
Japan). Analyzed by atomic force microscopy (SPA400, 
Seiko, Japan), appropriate amounts of PCL/DNA complexes 
were diluted with water and deposited onto a freshly cleaved 
mica substrate. Samples were imaged after evaporation 
to dryness by scanning a 5000 nm × 1000 nm area in tap-
ping mode using a NSG 10 cantilever with 190–325 kHz 
resonance frequencies and a constant force in the range of 
5.5–22.5 N/m. The images were recorded in air at room 
temperature and a scan speed of 1 Hz, and the phase image 
and topology were used to determine the morphology and 
particle size of the liposomes.
In vitro transfection PcL/DNA 
complexes in huh7 cells
Huh7 cells were seeded into 24-well plates at a density 
of 5 × 104 cells/cm2 in 1 mL of growth medium (DMEM 
containing 10% fetal bovine serum, supplemented with 
2 mM L-glutamine, 1% nonessential amino acid solution, 
100 U/mL penicillin, and 100 µg/mL streptomycin). The cells 
were grown in a humidified atmosphere (5% CO2, 95% air, 
37°C) for 24 hours. Prior to transfection, the medium was 
removed and the cells were rinsed with phosphate-buffered 
saline (pH 7.4). The cells were incubated with 0.5 mL of the 
PCL/DNA complexes at various weight ratios containing 
1 µg of pDNA for 24 hours at 37°C in a 5% CO2 atmosphere. 
Nontreated cells and cells transfected with naked plasmid, 
PEI/DNA complexes, and Lipofectamine 2000/DNA com-
plexes were used as controls. After transfection, the cells 
were washed twice with phosphate-buffered saline and 
grown in culture medium for 24 hours to allow for green 
fluorescent protein expression. All transfection experiments 
were performed in triplicate.
evaluation of cell viability
Evaluation of cytotoxicity was performed by the MTT assay. 
Huh7 cells were seeded in a 96-well plate at a density of 
5 × 104 cells/cm2 in 200 µL of growth medium and incu-
bated for 24 hours at 37°C in a 5% CO2 atmosphere. Prior 
to evaluation of cytotoxicity, the medium was removed and 
the cells were rinsed with phosphate-buffered saline. They 
were supplied with the PCL/DNA complexes in the same 
concentrations as for the in vitro transfection experiment. 
After treatment, the PCL/DNA complex solutions were 
removed. Finally, the cells were incubated with 100 µL 
MTT-containing medium (1 mg/mL) for four hours. Then the 
medium was removed, the cells were rinsed with phosphate-
buffered saline (pH 7.4), and formazan crystals formed in International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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living cells were dissolved in 100 µL dimethyl sulfoxide 
per well. Relative viability (%) was calculated based on 
absorbance at 550 nm using a microplate reader (Universal 
Microplate Analyzer, Models AOPUS01 and AI53601, 
  Packard BioScience, East Lyme, CT). The viability of non-
treated control cells was arbitrarily defined as 100%.
statistical analysis
The statistical significance of differences in transfection 
efficiency and cell viability were examined using one-way 
analysis of variance followed by a least-squares difference 
post hoc test. The significance level was set at P , 0.05.
Results and discussion
characterization of PcL/DNA complexes
In order to determine the optimal complexation conditions, 
it was necessary to evaluate the degree of binding between 
either PEI or PCL and DNA at different carrier concentrations. 
The formation of complexes between PCL and the pEGFP-C2 
plasmid DNA was visualized by agarose gel   electrophoresis. 
By varying the concentration of PCL and fixing the DNA 
concentration, the weight ratios of the particle formulations 
were varied (Figure 1; Lane 1, pEGFP-C2   plasmid; lanes 2–7, 
PCL/DNA complexes with weight ratios of 0.05, 0.1, 0.5, 
1, 5, and 10). As shown in Figure 1, PCL/DNA complexes 
showed different gene condensation patterns. In the case of 
PC/NaO liposomes (Figure 1A–C), complete complexes 
were formed at carrier/DNA weight ratios above 0.05 in all 
PC/NaO ratios (10:1, 10:1.5, and 10:2). On the other hand, 
PC/CHAPS (Figure 1D–F) and PC/NaT (Figure 1G–I) 
formed complete complexes with DNA at carrier/DNA 
weight ratios above 0.1, 0.05, and 0.05 for PC/CHAPS and 
PC/NaT at ratios of 10:1, 10:1.5, and 10.2, respectively. 
These results revealed that the NaO had a stronger binding 
ability to DNA than that of CHAPS and NaT.
Particle size and the zeta potential were plotted against 
weight ratios of PEI/DNA complexes (Figure 2A) and 
PCL/DNA complexes formulated with PEI-coated PC/NaO 
(10:2) liposomes (Figure 2B), PEI-coated PC/CHAPS (10:2) 
liposomes (Figure 2C), and PEI-coated PC/NaT (10:2) 
liposomes (Figure 2D). The particle sizes of the PEI/DNA 
complexes were in the 200–500 nm range (PDI 0.21–0.64) 
after a weight ratio of 0.75 (Figure 2A). The particle sizes of 
PLC formulated from PC/NaO and PC/CHAPS liposomes 
were slightly larger than the PEI/DNA complexes, whereas 
PLC formulated from PC/NaT showed the largest particle 
size (550–1595 nm). An initial negative value of the zeta 
potential was observed for all anionic liposomes (PC/NaO, 
PC/CHAPS, and PC/NaT). On the other hand, PEI-coated 
liposomes at 1:1 (w/w) showed positive values for the zeta 
potential. The zeta potential of all the PCL/DNA complexes 
was found to increase with increasing weight ratios of 
PCL, due to their higher density of protonated amines in 
the PCL. A similar result was observed in PEI (Figure 2A). 
  Morphological examination of the PEI-coated PC/NaO (10:2) 
liposome/DNA complexes at a weight ratio of 0.5 were 
performed by transmission electron microscopy and atomic 
force microscopy. The images revealed that the complexes 
were spherical and nanosized (Figure 3).
In vitro transfection
Achievement of high gene transfection efficiency is the final 
goal for the development of novel gene carriers. To investigate 
PCL-mediated gene transfection efficiency, an in vitro gene 
transfection assay was performed with a human hepatoma 
(Huh7) cell line using pEGFP-C2. PCL formulated with 
three kinds of anionic liposomes (PC/NaO, PC/CHAPS, and 
PC/NaT at molar ratios of 10:1, 10:1.5, and 10:2, respectively) 
and then coated with PEI at a weight ratio of 1:1. In order to 
investigate the optimal conditions for gene transfection, the 
PCL were complexed with DNA at various weight ratios of 
0.3, 0.4, 0.5, 0.75, 0.9, 1.0, and 1.5. PEI and Lipofectamine 
2000 complexed with DNA at weight ratios of 1 and 2, respec-
tively, were used as a positive control. In all studies, there 
were no transfection in controls (cells without complexes) 
and naked DNA. As shown in Figure 4 (at pH 7.4), the gene 
transfection efficiencies were significantly influenced by the 
carrier/DNA ratio and the type and ratio of surfactants used 
in the liposome formulation. For PC/NaO (Figure 4A–C) and 
PC/CHAPS (Figure 4D–F), by increasing the molar ratio of 
surfactant (from 10:1 to 10:2), the transfection efficiencies 
increased, and the highest values were observed at the molar 
ratio of 10:2, whereas the highest values of transfection effi-
ciencies of PC/NaT (Figure 4G–I) were at the molar ratio of 
10:1.5. In all PCL, the gene transfection efficiencies were 
significantly influenced by the carrier/DNA ratio. By increas-
ing the ratios, the transfection efficiencies reached the highest 
values with a decrease by further increment of the ratios. 
Among the carriers, PEI-coated PC/NaO (10:2) showed 
the highest transfection efficiency (Figure 4C). Some PCL 
formulations were much more effective in gene transfer than 
conventional polyplexes of PEI. PCL containing PC/NaO 
(10:2, carrier/DNA weight ratio 0.5) showed five times higher 
gene expression than the polyplex prepared with the same 
polymer of PEI (Figure 5A). These results suggest that PCL 
may have the dual advantages of being both   liposomes for International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
979
surfactants and gene transfection
cytosolic delivery of DNA and PEI for delivery of cytosolic 
DNA into the nucleus if PEI has the ability to enter into the 
nucleus in nondividing cells. Alternatively, if PEI cannot 
pass through the nuclear membrane, PEI still has ability to 
enhance the interaction of foreign DNA with chromatins 
during cell division.16,17
One of the major requirements for vectors used for gene 
delivery is low cytotoxicity. Therefore, the cytotoxicity study 
of the PCL/DNA complex was performed in Huh7 cells. 
Figure 5B shows the effect of carrier/DNA weight ratios 
(0.3, 0.4, 0.5, 0.75, 0.9, 1.0, and 1.5) on cell viability. When 
Huh7 cells were incubated with 1 µg of naked DNA, cell 
viability remained almost the same as that seen in nontrans-
fected control cells (data not shown). There was a significant 
decrease in cell viability when Huh7 cells were incubated 
with various weight ratios of both PEI/DNA and PCL/DNA 
complexes. Their average cell viability was decreased when 
the carrier/DNA weight ratio increased. However, viability 
was over 80% for the PCL/DNA complexes. Therefore, in 
this study, PCL were clearly demonstrated to be safe. This 
result is similar to that of a previous study by Hu et al20 who 
developed an efficient gene delivery system by combining 
PEI/DNA complexes, anionic liposomes, and a streptavidin-
monoclonal antibody. They showed that these lipopolyplexes 
helped to decrease cytotoxicity. Their in vitro experiment in 
SMMC-7721 cells showed that lipopolyplexes did not have 
significant toxicity. In contrast, PEI/DNA markedly reduced 
cell viability.
Previous studies have reported that the transfection effi-
ciency of lipoplexes and polyplex-associated gene expression 
was inhibited by serum. Serum was shown to inhibit trans-
fection activity depending on the charge and composition of 
the complexes. It is already known that anionic compounds 
present in serum often complex with positively charged 
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Figure 1 gel retarding analysis of PcL/DNA complexes formulated with A) Pc/NaO (10:1), B) Pc/NaO (10:1.5), C) Pc/NaO (10:2), D) Pc/chAPs (10:1), E) Pc/chAPs 
(10:1.5), F) Pc/chAPs (10:2), G) Pc/NaT (10:1), H) Pc/NaT (10:1.5), and I) Pc/NaT (10:2). Lane 1, pegFP-c2; lanes 2–7, PeI-coated liposomes (PcL)/DNA complexes at 
weight ratios of 0.05, 0.1, 0.5, 1, 5, and 10, respectively.
Abbreviations: Pc, phosphatidylcholine; PcL, polycationic liposomes; PeI, polyethylenimine; NaO, sodium oleate; NaT, sodium taurocholate; chAPs (3-[{3-cholamidopropyl}-
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transfection reagents, resulting in decreased transfection 
efficiency.21,22 These interactions result either in the dissocia-
tion of the complexes or in the formation of large aggregates, 
which, above a certain size limit, may be prevented from 
being internalized by cells.23
As shown in Figure 6, the effect of serum on transfec-
tion was dependent on the formulation. Association of gene 
  expression in PCL formulated with three kinds of anionic 
liposomes, ie, PC/NaO (10:2), PC/CHAPS (10:2), and 
PC/NaT (10:1.5), was observed in both the presence and 
absence of serum. For these experiments, the presence of 
10% serum in the transfection medium of pH 7.4 decreased 
the transfection efficiency of PCL formulated with PC/NaO 
(10:2) and PC/NaT (10:1.5), while that of PCL formulated 
with PC/CHAPS (10:2) was not significantly affected by the 
presence of serum. In this regard, it is reasonable to assume 
that the significant decrease in transfection activity mediated 
by complexes prepared from PC/NaO (10:2) and PC/NaT 
(10:1.5) in the presence of serum resulted from interac-
tions with serum proteins. In the case of PC/CHAPS (10:2), 
CHAPS is a cholic acid derivative in which the carboxylic acid 
has been amidated with the zwitterionic aminosulfonic acid 
moiety. Thus, it retains the same hydrophobic-  hydrophilic 
topology as the rest of the bile salt series except that they are 
formally neutral. CHAPS have gained widespread use in the 
solubilization and reconstitution of proteins. The solubiliza-
tion of membrane proteins is affected by the ionic character-
istics and critical micellar   concentration of   detergents. For the 
membrane   proteins, zwitterionic detergents were less efficient 
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Figure 3 A) Transmission electron microscopic (5000×) images, B) atomic force 
microscopic images of PeI-coated Pc/NaO (10:2) liposomes/DNA complexes at 
a weight ratio of 0.5.
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than ionic detergents.24,25 Thus, ionic detergents facilitated 
the incorporation of serum proteins. This observation is con-
sistent with previous reports   showing that the formulations 
containing cholesterol were more active in vivo than those 
containing dioleoyl phosphatidylethanolamine (DOPE), 
which has been attributed to their higher stability in biological 
fluids. This higher stability in the presence of serum is most 
likely due to the ability of cholesterol to confer membrane 
stability in contrast with DOPE, which is known to have an 
inverted cone shape that is associated with membrane fluid-
ity, thus facilitating binding and/or incorporation of serum 
proteins.26 Oku et al13 also reported that, in the presence of 
serum PCL composed of PC and cetylated PEI (P18C24), 
there was more enhanced gene transfer than without serum. 
On the contrary, the efficiency mediated by Dotap liposomes 
or Lipofectamine was markedly suppressed in the presence 
of serum. To clarify the reason for serum activation of 
PCL-mediated   transfection, they examined the formation of 
DNA-PCL complexes under the microscope. PCL and DNA 
appeared as rather heterogeneous aggregates in the absence 
of serum, but formed smaller and rather homogeneous ones 
in the presence of serum. In addition, Marchini et al showed 
that when serum was added, the transfection efficiency 
of all lipoplex formulations (didecyldimethylammonium   
bromide-dioleoylphosphatidylethanolamine and 3β[N-
(N’,N’-dimethylaminoethane)-carbamoyl] cholesterol-
dioleoylphosphatidylethanolamine) was found to increase. 
They identified structural stability and an increase in size 
in serum as major parameters regulating the efficiency of 
lipofection. By extrapolation, they proposed that serum, 
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Notes: each value represents the mean ± standard deviation of three wells. * statistically significant (P , 0.05).
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regulating the size of resistant lipid-DNA complexes, can 
control the mechanism of internalization of lipoplexes and, 
in turn, their efficiency.27 Although conflicting reports exist 
regarding the optimal size of lipoplexes for lipofection, there 
is no doubt that high lipofection would be gained from large 
lipoplexes when endocytosis is dominant, because large 
particles   facilitate membrane contact and fusion. When the 
type of cell is not an actively endocytosing cell, either small 
particles may have high transfection efficiency, or lipoplex 
size may not correlate with lipofection efficiency. In   addition 
to lipoplex size, different conditions (such as cationic 
  lipids, cell types and in vivo/in vitro) may result in different 
  transfection efficiency.28
Conclusion
In this study, we have developed PEI-coated anionic lipo-
somes as efficient gene carriers. PCL composed of PC:NaO 
(10:2) showed superior transfection efficiency with NaT and 
CHAPS at all weight ratios tested, while for PC/CHAPS the 
transfection capability did not alter even in the presence of 
serum. This study suggests that PCL is safe and exhibits 
a significantly improved gene delivery capability in vitro. 
Because both PEI and liposomes can be easily modified with 
various ligands, these lipopolyplexes might be useful in the 
design of targeted carriers specific for cell-surface receptors 
in the delivery of therapeutic genes.
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